ヘモクロマトーシス (血液染色体病)
1University Hospital, London, ON, Canada. padams@uwo.ca
Lancet (London, England)
|December 7, 2007
まとめ
遺伝性ヘモクロマトーシスは,一般的な遺伝疾患である. 深刻な肝疾患を発症する人もいますが,C282Y変異のキャリアの多くは無症状であり,パーソナライズされたモニタリングと治療の必要性を強調しています.
科学分野:
- 遺伝学 遺伝学とは
- 肝臓病理学 肝臓病理学
- 内科内科は,内科の内科である.
背景:
- 1996年に発見されたHFE遺伝子に関連した遺伝性血色変異症は,一般的な遺伝疾患です.
- 臨床的な表現は,無症状の個体から,高い死亡率を持つ重度の肝硬変まで幅広く異なります.
- 集団スクリーニングでは,鉄過負荷を発症しない多数の無症状C282Y変異ホモジゴットを特定しました.
研究 の 目的:
- 遺伝性血色腫症の理解における最近の進歩を要約します.
- C282Y変異の可変性浸透性を強調するために.
- 診断マーカーと治療結果について議論する.
主な方法:
- 遺伝性ヘモクロマトーシスに関する既存の文献のレビュー.
- C282Y変異媒体の集団スクリーニングデータの分析.
- トランスフェリン飽和度,血清フェリチンなどの診断検査の評価.
- フレボトミー療法の有効性の評価.
主要な成果:
- C282Y変異を持つ多くの個体は,同胞性にもかかわらず,無症状のままである.
- トランスフリン飽和度および血清フェリチンは,有用な診断指標です.
- フレボトミー治療は,肝繊維症の改善に有効であることが示されています.
- 遺伝性ヘモクロマトーシスの遺伝子検査は一般的によく受け入れられています.
結論:
- 遺伝性ヘモクロマトーシスは,変化する臨床浸透率を示します.
- 早期診断とモニタリングは,疾患の管理に不可欠です.
- フレボトミーは,罹患した人のための重要な治療的介入です.
関連する概念動画
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:16Necrosis
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...